AZD1390 FOR RECURRENT GLIOBLASTOMA
  • March 15, 2022
A Phase 0/1b clinical trial to evaluate AZD1390 in patients with recurrent glioblastoma.
Learn More
SONODYNAMIC THERAPY IN RECURRENT HIGH-GRADE GLIOMA
  • March 5, 2022
A Phase 0 research study of intravenous Aminolevulinic Acid Hydrochloride (ALA) and MR-guided focused ultrasound device (MRgFUS) in recurrent high-grade glioma patients
Learn More
INFIGRATINIB FOR RECURRENT HIGH-GRADE GLIOMA
  • February 4, 2021
A Phase 0 study of infigratinib in recurrent high-grade glioma patients with an FGFR gene fusion scheduled for resection to evaluate central nervous system (CNS) penetration with PK triggered expansion cohort
Learn More
RIBOCICLIB PLUS EVEROLIMUS FOR RECURRENT HIGH-GRADE GLIOMA
  • February 1, 2021
A Phase 0/2 study of ribociclib in combination with everolimus in preoperative Rb-intact recurrent high-grade glioma patients scheduled for resection
Learn More